Falagas Matthew E, Karagiannis Apostolos K A, Nakouti Theodora, Tansarli Giannoula S
Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece; Department of Internal Medicine-Infectious Diseases, Iaso General Hospital, Iaso Group, Athens, Greece; Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, United States of America.
Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece.
PLoS One. 2015 Jan 5;10(1):e0116207. doi: 10.1371/journal.pone.0116207. eCollection 2015.
To investigate whether compliance of patients to antibiotic treatment is better when antibiotics are administered once than multiple times daily.
We performed a systematic search in PubMed and Scopus databases. Only randomized controlled trials were considered eligible for inclusion. Compliance to antibiotic treatment was the outcome of the meta-analysis.
Twenty-six studies including 8246 patients with upper respiratory tract infections in the vast majority met the inclusion criteria. In total, higher compliance was found among patients treated with once-daily treatment than those receiving treatment twice, thrice or four times daily [5011 patients, RR=1.22 (95% CI, 1.11, 1.34]. Adults receiving an antibiotic once-daily were more compliant than those receiving the same antibiotic multiple times daily [380 patients, RR=1.09 (95% CI, 1.02, 1.16)]. Likewise, children that received an antibiotic twice-daily were more compliant than those receiving the same antibiotic thrice-daily [2118 patients, RR=1.10 (95% CI, 1.02, 1.19)]. Higher compliance was also found among patients receiving an antibiotic once compared to those receiving an antibiotic of different class thrice or four times daily [395 patients, RR=1.20 (95% CI, 1.12, 1.28)]. The finding of better compliance with lower frequency daily was consistent regardless of the study design, and treatment duration.
This meta-analysis showed that compliance to antibiotic treatment might be associated with higher when an antibiotic is administered once than multiple times daily for the treatment of specific infections and for specific classes of antibiotics.
研究抗生素每日给药一次时患者对抗生素治疗的依从性是否优于每日多次给药。
我们在PubMed和Scopus数据库中进行了系统检索。仅纳入随机对照试验。抗生素治疗的依从性是荟萃分析的结果。
26项研究符合纳入标准,绝大多数研究纳入了8246例上呼吸道感染患者。总体而言,每日一次治疗的患者比每日两次、三次或四次治疗的患者依从性更高[5011例患者,RR=1.22(95%CI,1.11,1.34)]。每日一次接受抗生素治疗的成年人比每日多次接受相同抗生素治疗的成年人依从性更高[380例患者,RR=1.09(95%CI,1.02,1.16)]。同样,每日两次接受抗生素治疗的儿童比每日三次接受相同抗生素治疗的儿童依从性更高[2118例患者,RR=1.10(95%CI,1.02,1.19)]。与每日三次或四次接受不同类别抗生素治疗的患者相比,每日一次接受抗生素治疗的患者依从性也更高[395例患者,RR=1.20(95%CI,1.12,1.28)]。无论研究设计和治疗持续时间如何,每日给药频率较低时依从性更好这一发现都是一致的。
这项荟萃分析表明,对于特定感染和特定类别的抗生素治疗,每日一次给予抗生素时患者对抗生素治疗的依从性可能更高。